Mygenetx Laboratory LLC

Mygenetx Laboratory LLC was paid $34K by Medicaid between Sep 2020 and Dec 2024, across 38 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 68% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Tennessee

Rank by total paid#45 of 70

Median peer was paid$141K

This provider vs. median0.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,076	$22K
2022	677	$2K
2023	1,757	$3K
2024incomplete	3,328	$7K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	68%	1,139	301	$23K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	8.7%	603	114	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	4.0%	274	221	$1K
80053	Comprehensive metabolic panel	2.7%	445	366	$925.95
87481		2.2%	88	86	$760.45
84443	Thyroid stimulating hormone (TSH)	1.9%	290	230	$638.59
80061	Lipid panel	1.8%	248	195	$629.81
83036	Hemoglobin; glycosylated (A1C)	1.6%	335	278	$537.95
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.2%	391	276	$421.62
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.1%	62	21	$375.00
82607		<1%	175	150	$263.58
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	406	186	$257.94

26 more codes

83880		<1%	146	$235.60
36415	Collection of venous blood by venipuncture	<1%	415	$214.77
85027		<1%	270	$201.42
87640		<1%	118	$181.92
87653		<1%	89	$169.15
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	117	$156.38
84439		<1%	165	$126.55
83540		<1%	108	$110.36
80048	Basic metabolic panel (calcium, ionized)	<1%	241	$101.13
82746		<1%	86	$61.13
84481		<1%	77	$56.06
87563		<1%	68	$52.65
82728		<1%	23	$42.41
84403		<1%	32	$35.22
84270		<1%	32	$29.66
83718		<1%	20	$28.75
83735		<1%	37	$22.18
84478		<1%	20	$20.15
82465		<1%	20	$15.28
83550		<1%	58	$14.34
83721		<1%	60	$13.02
84100		<1%	27	$10.02
84550		<1%	59	$9.24
86140		<1%	55	$3.53
81000		<1%	26	$2.16
82670		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMIZELL, TROY (PRESIDENT)